methylphenidate vs risperidone
Side-by-side comparison of methylphenidate and risperidone. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
moderate Known Drug Interaction
Methylphenidate Concomitant use with methylphenidate, when there is change in dosage of either medication, may increase the risk of extrapyramidal symptoms (EPS). Monitor for symptoms of EPS with concomitant use of risperidone tablets and methylphenidate [see Adverse Reactions ( 6.2 )].
Recommendation: Watch for signs of muscle stiffness or shaking and let your doctor know if these symptoms occur.
Ritalin, Concerta
Risperdal
Methylphenidate extended-release capsules are a stimulant medicine. They are used to treat Attention Deficit Hyperactivity Disorder (ADHD) in children ages 6 to 12.
Risperidone is a medicine used to treat certain mental disorders. It can help reduce symptoms like hallucinations, delusions, and aggression.
This medicine treats Attention Deficit Hyperactivity Disorder (ADHD) in children. ADHD can make it hard to focus, pay attention, and control impulsive behavior. This medicine can help improve focus and reduce hyperactivity.
Risperidone is used to treat schizophrenia in adults and teens. It also treats manic or mixed episodes of bipolar I disorder, either alone or with lithium or valproate. Additionally, it can help with irritability, including aggression and self-injury, in children and teens with autism.
Methylphenidate is a central nervous system (CNS) stimulant. It works by affecting chemicals in the brain that contribute to hyperactivity and impulsivity. The extended-release capsules release the medicine in two stages, providing both an immediate and a delayed effect.
Risperidone works by changing the levels of certain natural substances in the brain. These substances are called neurotransmitters. By balancing these chemicals, risperidone can reduce symptoms of mental disorders.
- • Headache
- • Trouble sleeping (insomnia)
- • Upper abdominal pain
- • Decreased appetite
- • Loss of appetite (anorexia)
- • Parkinsonism (slowed movement, stiffness)
- • Restlessness
- • Muscle stiffness or spasms
- • Tremors
- • Sleepiness
- Problem with the quality of the medicine 5,241
- Mistake in giving the medicine 1,901
- Incorrect way of using the medicine 1,772
- Redness where the medicine was applied 1,684
- Skipping a dose of the medicine 1,478
- Breast enlargement in males 24,608
- Unusual weight gain 9,446
- Weight gain 9,089
- Mental or emotional problem 5,947
- Harm or damage to the body 4,624
This medicine has a high potential for abuse and dependence. Your doctor will assess your risk before prescribing it and monitor you during treatment. Misuse of this medicine may cause sudden death or serious heart problems.
Risperidone may increase the risk of death in elderly patients who have dementia-related psychosis. Risperidone is not approved for treating dementia-related psychosis.
Tell your doctor if you are pregnant or plan to become pregnant. It is not known if this medicine will harm your unborn baby. There is a pregnancy registry for women who take ADHD medicines during pregnancy.
Tell your doctor if you are pregnant or plan to become pregnant. Babies born to mothers who take risperidone in the last 3 months of pregnancy may have withdrawal symptoms or other problems after birth. There is a pregnancy registry to monitor outcomes in women exposed to risperidone during pregnancy. You can contact the registry at 1-866-961-2388.
Also Compare, Nearby Drugs
Compare methylphenidate with
Compare risperidone with
How to Read This methylphenidate vs risperidone Comparison
methylphenidate is classified in the CNS Stimulant drug class, while risperidone sits within the Atypical Antipsychotic class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, methylphenidate has 12,076 submissions while risperidone has 53,714. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known moderate interaction flagged in FDA labeling, attributed to combining these medicines can increase the chance of developing movement problems, especially if the dose of either drug is changed.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between methylphenidate and risperidone - always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.